Less than 1% of bats carry Ebola antibodies, according to a study by IRD

A study conducted by Placide Mbala-Kingebeni at the Institute for Research and Development reveals that less than 1% of bats in the Democratic Republic of the Congo, Guinea, and Cameroon carry antibodies against the Ebola virus. This research, validated by international co-supervision, highlights the importance of continuing efforts to identify the reservoir of the virus and prevent outbreaks.

Research on the Ebola virus has long been hindered by uncertainty regarding its animal reservoir, a crucial topic for public health. The work of Placide Mbala-Kingebeni, in collaboration with IRD and INSERM, sheds light on the prevalence of anti-Ebola virus antibodies in wildlife, revealing that less than 1% of the bats tested show antibodies.

The study analyzed bat samples from several African countries, showing that antibody detection is rare and no viral RNA was found, even during epidemic periods. These results underscore the need for continued research to better understand the transmission dynamics of the Ebola virus.

The implications of this research are significant for policymakers and health professionals. It is recommended to develop zoonotic disease surveillance programs to prevent Ebola virus outbreaks, by investing in research and monitoring to better understand and manage associated risks.

« « Less than 1% of the bats tested carry antibodies against the Ebola virus, which raises questions about their potential role as a reservoir, » says Placide Mbala-Kingebeni. »

« « This research highlights the importance of accessing reliable data to guide public health decisions and epidemic prevention, » emphasizes the Lektaris team. »